Overview
- Johnson & Johnson signed a 10-year incumbency with Fujifilm Biotechnologies to operate a 160,000-square-foot facility at the Holly Springs campus in North Carolina.
- The commitment totals about $2 billion over the term, and J&J has not disclosed specific product allocations or a detailed startup timeline.
- The project is expected to add roughly 100 to 120 jobs locally as Fujifilm targets hub operations in 2025 after investing about $3.2 billion.
- Regeneron previously secured a separate 10-year, $3 billion incumbency at the same site, highlighting the multi-tenant CDMO model for large-scale cell-culture manufacturing.
- J&J said it will outline additional U.S. facility plans in the coming months, complementing a separate Wilson, North Carolina biologics site announced in 2024.